Elevance Health, Inc. (ELV)
(Delayed Data from NYSE)
$533.73 USD
+0.81 (0.15%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $533.76 +0.03 (0.01%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth B Momentum A VGM
Balance Sheet
Fiscal Year End for Elevance Health, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 36,369 | 34,292 | 33,028 | 30,733 | 25,988 |
Receivables | 17,865 | 16,044 | 13,440 | 10,958 | 10,553 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 5,795 | 5,281 | 4,654 | 4,060 | 2,492 |
Total Current Assets | 60,029 | 55,617 | 51,122 | 45,751 | 39,033 |
Net Property & Equipment | 4,359 | 4,316 | 3,919 | 3,483 | 3,133 |
Investments & Advances | 6,983 | 6,437 | 5,857 | 4,847 | 4,763 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 35,590 | 34,698 | 34,843 | 31,096 | 29,174 |
Deposits & Other Assets | 1,967 | 1,704 | 1,719 | 1,438 | 1,350 |
Total Assets | 108,928 | 102,772 | 97,460 | 86,615 | 77,453 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 225 | 265 | 275 | 0 | 1,051 |
Accounts Payable | 23,021 | 21,203 | 18,488 | 16,852 | 13,209 |
Current Portion Long-Term Debt | 1,649 | 1,500 | 1,599 | 700 | 1,598 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 16,896 | 16,728 | 14,523 | 11,901 | 7,759 |
Total Current Liabilities | 41,791 | 39,696 | 34,885 | 29,453 | 23,617 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 1,970 | 2,034 | 2,805 | 2,019 | 2,227 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 23,246 | 22,349 | 21,157 | 19,335 | 17,787 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 2,516 | 2,299 | 2,485 | 2,609 | 2,094 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 69,523 | 66,378 | 61,332 | 53,416 | 45,725 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 2 | 2 | 2 | 3 | 3 |
Capital Surplus | 8,868 | 9,084 | 9,148 | 9,244 | 9,448 |
Retained Earnings | 31,749 | 29,724 | 27,088 | 23,802 | 22,573 |
Other Equity | -1,214 | -2,416 | -110 | 150 | -296 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 39,405 | 36,394 | 36,128 | 33,199 | 31,728 |
Total Liabilities & Shareholder's Equity | 108,928 | 102,772 | 97,460 | 86,615 | 77,453 |
Total Common Equity | 39,405 | 36,394 | 36,128 | 33,199 | 31,728 |
Shares Outstanding | 233.00 | 240.00 | 242.70 | 248.70 | 253.50 |
Book Value Per Share | 169.12 | 151.64 | 148.86 | 133.49 | 125.16 |
Fiscal Year End for Elevance Health, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 36,267 | 36,369 | 38,895 | 38,284 | 38,170 |
Receivables | 18,293 | 17,865 | 16,932 | 16,523 | 16,710 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 6,388 | 5,795 | 5,358 | 4,936 | 4,943 |
Total Current Assets | 60,948 | 60,029 | 61,185 | 59,743 | 59,823 |
Net Property & Equipment | 4,451 | 4,359 | 4,248 | 4,547 | 4,418 |
Investments & Advances | 7,593 | 6,983 | 6,934 | 6,768 | 6,754 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 36,657 | 35,590 | 35,782 | 35,977 | 36,188 |
Deposits & Other Assets | 2,245 | 1,967 | 2,329 | 2,133 | 1,857 |
Total Assets | 111,894 | 108,928 | 110,478 | 109,168 | 109,040 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | 1,575 | 225 | 0 | 265 | 265 |
Accounts Payable | 22,117 | 23,021 | 22,159 | 21,198 | 20,601 |
Current Portion Long-Term Debt | 2,900 | 1,649 | 799 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 17,742 | 16,896 | 20,379 | 20,108 | 21,023 |
Total Current Liabilities | 44,334 | 41,791 | 43,337 | 41,571 | 41,889 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 2,201 | 1,970 | 1,779 | 1,852 | 2,029 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 21,976 | 23,246 | 24,045 | 24,859 | 25,201 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 2,673 | 2,778 | 2,574 | 2,461 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 71,184 | 69,523 | 71,939 | 70,856 | 71,580 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 2 | 2 | 2 | 2 | 2 |
Capital Surplus | 8,883 | 8,868 | 8,830 | 8,761 | 8,697 |
Retained Earnings | 33,088 | 31,749 | 32,103 | 31,608 | 30,707 |
Other Equity | -1,263 | -1,214 | -2,396 | -2,059 | -1,946 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 40,710 | 39,405 | 38,539 | 38,312 | 37,460 |
Total Liabilities & Shareholder's Equity | 111,894 | 108,928 | 110,478 | 109,168 | 109,040 |
Total Common Equity | 40,710 | 39,405 | 38,539 | 38,312 | 37,460 |
Shares Outstanding | 232.40 | 233.00 | 234.90 | 235.60 | 237.00 |
Book Value Per Share | 175.17 | 169.12 | 164.07 | 162.61 | 158.06 |